1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario registrado en Universia


Detalles del recurso

Descripción

Rapamycin is used frequently in both transplantation and oncology. Although historically thought to have little diabetogenic effect, there is growing evidence of β-cell toxicity. This Review draws evidence for rapamycin toxicity from clinical studies of islet and renal transplantation, and of rapamycin as an anticancer agent, as well as from experimental studies. Together, these studies provide evidence that rapamycin has significant detrimental effects on β-cell function and survival and peripheral insulin resistance. The mechanism of action of rapamycin is via inhibition of mammalian target of rapamycin (mTOR). This Review describes the complex mTOR signaling pathways, which control vital cellular functions including mRNA translation, cell proliferation, cell growth, differentiation, angiogenesis, and apoptosis, and examines molecular mechanisms for rapamycin toxicity in β-cells. These mechanisms include reductions in β-cell size, mass, proliferation and insulin secretion alongside increases in apoptosis, autophagy, and peripheral insulin resistance. These data bring into question the use of rapamycin as an immunosuppressant in islet transplantation and as a second-line agent in other transplant recipients developing new-onset diabetes after transplantation with calcineurin inhibitors. It also highlights the importance of close monitoring of blood glucose levels in patients taking rapamycin as an anticancer treatment, particularly those with preexisting glucose intolerance. The macrolide rapamycin is both an antiproliferative and potent immunosuppressant. It is produced commercially as sirolimus and its derivative, everolimus. Sirolimus is predominantly used as an immunosuppressant in transplantation, while everolimus is used mainly as an anticancer agent. Early data suggested little or no diabetogenic effects of rapamycin, particularly in comparison with other immunosuppressants, and it was this that prompted its use in islet cell transplantation. It was also for this reason that rapamycin has been promoted as a second-line therapy for recipients of solid organ transplants who have developed new-onset diabetes after transplantation (NODAT) while taking calcineurin inhibitors (CNIs). However, there is an increasing view that rapamycin has profound effects on pancreatic β-cells, as well as altering insulin sensitivity. Evidence for this arises from in vitro and in vivo experiments and clinical studies. This article will review this evidence and also explore the potential mechanisms of rapamycin toxicity, drawn from experiments of β-cell physiology.

Pertenece a

Faculty of Technology ePrints Service  

Autor(es)

Barlow, A. D. -  Nicholson, M. L. -  Herbert, T. P. - 

Id.: 70171862

Versión: 1.0

Estado: Final

Palabras claveB200 Pharmacology, Toxicology and Pharmacy - 

Tipo de recurso: Article  -  PeerReviewed  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

Requerimientos técnicos:  Browser: Any - 

Relación: [References] http://eprints.lincoln.ac.uk/28219/
[References] 10.2337/db13-0106

Fecha de contribución: 02-nov-2017

Contacto:

Localización:
* Barlow, A. D. and Nicholson, M. L. and Herbert, T. P. (2013) Evidence for rapamycin toxicity in pancreatic b-Cells and a review of the underlying molecular mechanisms. Diabetes, 62 (8). pp. 2674-2682. ISSN 0012-1797

Otros recursos del mismo autor(es)

  1. Distinct signalling pathways mediate insulin and phorbol ester- stimulated eukaryotic initiation factor 4F assembly and protein synthesis in HEK 293 cells Stimulation of serum-starved human embryonic kidney (HEK) 293 cells with either the phorbol ester, 1...
  2. Cooperativity between the preproinsulin mRNA untranslated regions Is necessary for glucose-stimulated translation Glucose regulates proinsulin biosynthesis via stimulation of the translation of the preproinsulin mR...
  3. The selective recruitment of mRNA to the ER and an increase in initiation are important for glucose-stimulated proinsulin synthesis in pancreatic β-cells Glucose acutely stimulates proinsulin synthesis in pancreatic β-cells through a poorly understood po...
  4. A decrease in cellular energy status stimulates PERK-dependent eIF2α phosphorylation and regulates protein synthesis in pancreatic β-cells In the present study, we demonstrate that, in pancreatic β-cells, eIF2α (eukaryotic initiation facto...
  5. Molecular mechanisms of muscarinic acetylcholine receptor-stimulated increase in cytosolic free Ca2+ concentration and ERK1/2 activation in the MIN6 pancreatic b-cell line Muscarinic acetylcholine receptor (mAChR) activation of pancreatic β-cells elevates intracellular Ca...

Otros recursos de la mismacolección

  1. Genetic rescue of absence seizures Crossbreeding GABAAR δ subunit knockout mice with stargazer mice removes the absence seizure phenoty...
  2. Yearning to belong: finding a "home" for the right to academic freedom in the UN human rights covenants Academic freedom is generally considered a human right, both nationally and internationally. However...
  3. Self-disclosure with dogs: dog owners’ and non-dog owners’ willingness to disclose emotional topics Many owners talk to their pets about a wide range of issues, but there is very little research that ...
  4. Changing nature and emerging patterns of domestic violence in global contexts: dowry abuse and the transnational abandonment of wives in India This paper argues for the need to understand dowry-related abuse through a lens that focuses not onl...
  5. The Better Insulated House Programme The Better Insulated House Programme was conceived in 1973 in awareness of the imminent world shorta...

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.